Efficient immune responses require interactions between cell adhesion molecules on lymphocytes and counter-receptors on antigen presenting cells or target cells. While target-specific receptors or ligands have not been identified for natural killer (NK) cells, cell adhesion molecules have been implicated in the interaction between NK cell effectors and tumor cell targets. Herein, we describe monodonal antibodies (mAbs) against a carcinoma cell line that efficiently block the cytolytic activity of interleukin 2-activated NK cell lines and clones. L280 mAb reacts with secretory epithelial cells in normal human tissues, but does not react with hematopoietic cells or other tissue types. Biochemical analysis revealed that L280 mAb immunoprecipitates the ~4,c~6 integrin, as well as a novel 98-kD glycoprotein, and probably reacts with a carbohydrate epitope on these molecules. Involvement of the L280 antigen in cellular immunity is not restricted to NK cell-mediated cytotoxicity. L280 mAb also efficiently inhibits aUoantigen-specific cytotoxicity against Colo-205 cells mediated by human histocompatibility leukocyte antigen (HLA)-A2 alloantigen specific o~B-TCR + and 3,&TCR + cytotoxic T lymphocyte (CTL) clones. Additionally, we demonstrate that L280 mAb blocks cytotoxicity mediated by influenza peptide-specific HLA-restricted CTL clones. These data indicate that the antigen recognized by L280 mAb is important in both NK and CTL function, and that an as yet unidentified receptor for this epithelial antigen is present on both NK and T lymphocytes. The restricted expression of L280 antigen indicates that this molecule may be important in immune reactions in epithelial tissues.
T lymphocytes recognize antigen via the CD3/T cell antigen receptor complex (1) . In addition to the antigenspecific receptor, other T cell surface molecules are essential for interaction of helper T cells with APC or CTL with target cells (2) (3) (4) . These have been referred to as "accessory" or "cell adhesion" molecules. Cell adhesion molecules present on the effector T cell can interact with cellular ligands or "counterreceptors" on the membranes of APC or target cells. Recent studies have indicated that a vast array of membrane structures are involved in inter-cellular binding and signaling. Interaction of these accessory molecules can be critical to the generation of an immune response. For example, alloantigen specific helper T cells fail to produce cytokines in response to HLA-DR7 antigen expressed in murine L cells. However, cotransfection of HLA-DR7 and CD54 (ICAM-1), a cellular ligand for CDll/18 (LFA-1), restores T cell responsiveness (5) . Thus, antigen-specific recognition alone may be insuffident to trigger effector function, since additional accessory molecules are required for an efficient response.
NK cells are a population of lymphocytes identified by the phenotype CD3e-,CD56 + that mediate major histocompatibility complex unrestricted cytotoxicity against certain malignant and virus-infected cells, and produce numerous cytokines following immune stimulation (6) . The cell surface receptors on NK cells that are involved in target cell recognition have not been identified. There is considerable debate whether NK cells possess "specific" receptors for targets or alternatively whether the cytotoxic function can be initiated simply by appropriate engagement of cell adhesion molecules (7) . Nonetheless, as with T cells, cell adhesion molecules are certainly involved in the interaction between NK cells and their targets. Although 82 integrin (CDll/18) and CD2 have been implicated in certain NK/target cell interactions (8) (9) (10) , in general the cell surface molecules involved in NK cell interactions with target cells have not been identified. NK cells constitutively express intermediate affinity receptors for IL-2 and are able to kill a broad spectrum of tumor cell targets after activation by Ib2 (11) (12) (13) . Colo-205 is a human colon adenocarcinoma cell line that is resistant to killing by resting peripheral blood NK cells, but is efficiently lysed by IL-2-activated NK cells (12) . mAbs were generated against this tumor in order to identify the membrane structures involved in the interaction between NK cells and carcinoma targets. In this report, we describe mAbs that react with normal secretory epithelial tissues and recognize a/34, or6 integrin-associated antigen on the membrane of Colo-205. The role of this antigen in NK and CTL cytotoxicity is examined. Cytotoxicity Assay. Tumor cell lines (~1.5 x 106 cells) were labeled with 100 #Ci SlCr for 3 h, washed, and used as targets in a 4-h radioisotope release cytotoxicity assay (21) . For antigenpulsing, specific influenza peptide was added at 20 #M during the 3-h incubation for SlCr labding.
Materials and Methods

HTbridomas and
Immunohistology. Frozen sections of human colon, breast, lung, and stomach tissue obtained from normal autopsy tissue were stained with control Ig or L280 mAb at saturating concentrations, followed by horseradish peroxidase conjugated goat anti-mouse Ig as a second step.
Flow Cytometry. Methods of immunofluorescence and flow cytometryhave been described previously (21) . Flow cytometry was performed using a FACScan | or FACStar ~ (Becton Dickinson Immunocytometry Systems).
Biochemistry. Colo-205 and HT-29 ceils were surface labeled with mI (Amersham Corp., Arlington Heights, IL) and were solubilized in "Iris buffered saline (TBS, 50 mM "Iris, 150 mM NaC1, pH 8.0) containing 1% NP-40, 20 Kallikrein inhibitor U/ml aprotinin (Sigma Chemical Co., St. Louis, MO), and I mM PMSF (Sigma Chemical Co.) (22) . Cell lysates were passed through a 0.2 ml (bed volume) column of Dowex 1 • 8-400 (chloride form; Sigma Chemical Co.) equilibrated in TBS to remove unbound mI, and were precleared three times with 10 mg Pansorbin (CalbiochemBehring Corp., San Diego, CA) coated with saturating amounts of rabbit anti-mouse Ig serum (22) . Lysates were passed through lentil lectin-Sepharose 4B (Pharmada Fine Chemicals) equilibrated in loading buffer (10 mM Tris, 150 mM NaCI, 0.25% NP-40, 0.05% NAN3, pH 7.4) and glycoproteins eluted in loading buffer containing 300 mM 1-O-methyl c~ D-glucopyranoside (Sigma Chemical Co.). Antigens were immunoprecipitated using Pansorbin coated with saturating amounts of rabbit anti-mouse Ig and mAb (22) . Immunoprecipitates were washed five times in TBS containing 1% NP-40. For removal of N-linked oligosaccharides, immunoprecipitates were treated with 65 U/m1 endo-F (New England Nuclear, Boston, MA) for 24 h at 37~ in the presence of 1 mM PMSF and 50 mM EDTA (23) . For reprecipitation experiments, ~zSI-labeled lentil lectin purified Colo-205 glycoproteins were incubated for 2 h with 25 #1 Sepharose 4B coupled by CNBr to L280 mAb (~3 mg Ig/ml beads) or 3E1 mAb (24) . Beads were washed five times in 1% NP-40 TBS, and antigen was duted in 50 #150 mM diethylamine (pH 12) and immediatdy neutralized with 50 #1 1 M "Iris, pH 7.6. Eluted antigen was diluted to 1 ml in cold 1% NP-40 TBS containing 10 mg/ml BSA and 1 mM PMSF (Sigma Chemical Co.) and used for reimmunoprecipitation experiments. Samples were analyzed by SDS-PAGE under reducing conditions, or by two-dimensional diagonal SDS-PAGE (first dimension nonreducing, second dimension reducing) using 7.5 % acrylamide gels (22) .
Results and Discussion
Generation of mA bs Inhibiting Interleulein (IL)-2 Activated Natural Killer (NK) Cell Cytotoxicity. To identify the membrane structures involved in the killing of carcinomas by Ib2 activated NK cells, mAbs were generated against Colo-205 and selected for their ability to inhibit cytotoxicity mediated by I1.2 activated NK cells, mAbs, designated L279 (IgG3,K isotype), L280 (IgG1,K) and L281 (IgM, g), were identified that efficiently blocked NK cell-mediated cytotoxicity against Colo-205 ( Fig. 1 A) , but not other tumor ceU targets, including K562, JY, LoVo, HT-29, and BDMEL-1 (not shown). Potent inhibition of cytotoxicity was achieved with relatively low concentrations of purified L280 mAb (Fig. 1 B) . These mAbs inhibited the cytolytic activity of polyclonal populations of peripheral blood NK cells cultured in II-2, as well as I1-2-dependent NK clones, established from more than 20 individuals. All NK cells lines that mediated cytotoxicity against Colo-205 were efficiently inhibited with L280 mAb. Since L279, L280, and L280 mAbs were all determined to immunoprecipitate the same structure, subsequent experiments were performed with only L280 mAb. teratocarcinoma cell line (PA-1) and melanoma cell lines (SKMEbl, BDMEL-1, BDMEI.-2), were also unreactive. However, immunohistochemical staining of normal tissues indicated that the antigen recognized by L280 mAb is abundantly expressed in vivo. As shown in Fig. 3 , L280 mAb specifically reacted with secretory epithelial cells in colon, breast, lung and stomach. Secretory epithdial cells of the duodenum and jejunal mucosa, salivary glands, and skin were also stained with this mAb (not shown). In lymphoid tissues, (continued) L280 mAb prominently stained the epithelial crypts of the palatine tonsil and thymic Hassall's corpusdes (not shown), but did not react with hematopoietic cells. Given the broad distribution in normal tissues, it was surprising that the carcinoma cell lines other than Colo-205 that were examined failed to react with L280 mAb. It is possible that expression of the antigen is lost during transformation or during in vitro culture. A more extensive examination of primary carcinomas before and after culture will be necessary to resolve this issue. Nonetheless, the antigen recognized by L280 mAb is abundantly distributed on normal epithelial tissues in vivo, demonstrating that the antigen is not "tumor-associated" or restricted to expression on the Colo-205 cell line.
Distribution of the Antigen Recognized by L280 raAh
Biochemical Characterization. Colo-205 cells were surfacelabeled with 12Sl, detergent solubilized and glycoproteins isolated by lentil lectin affinity chromatography. At least 5 proteins (170, 150, 135, 118, and 98 kD) were immunoprecipitated using the L280 mAb (Fig. 4 A) , L279, and L281 mAb (not shown). Direct comparison of the unfractionated, lentil-lectin bound, and nonbinding antigens revealed no substantial qualitative differences in the structures immunoprecipitated with L280 mAb and indicated the L280 mAb reactive glycoproteins were essentially exclusively in the lentil-lectin bound fraction (not shown). Since an initial lentil-lectin chromatography step resulted in substantially lower backgrounds in the immunoprecipitation experiments, we routinely incorporated this step in subsequent experiments. Two-dimensional diagonal gel electrophoresis (first dimension, nonreduced; second dimension, reduced) revealed that the 170-, 150-, 118-, and 98-kD proteins migrated either on or slightly above the diagonal, indicating the presence of possible intrachain disulfide bonds, but lack of interchain disulfide linkages to other proteins (Fig. 4 B) . However, the 135-kD subunit migrated below the diagonal due to the cleavage of a small disulfide linked component of,o25 kD, that was only revealed in subsequent experiments using gradient gels (not shown).
The 170-, 150-, 135-, 118-kD proteins appeared very similar to the fl4,cr6 integrin that is preferentially expressed on colon carcinomas (20, (25) (26) (27) . Location of the 135-kD subunit below the diagonal was consistent with the migration of or6 integrin on diagonal gels, as reported by Hemler and colleagues (26) . Moreover, as with prior studies describing the f14,ot6 integrin, the relative labeling intensity of the different chains varied between experiments, and in some experiments an ad-ditional band of ,o190 kD was observed. Recent studies have indicated that f14 exists in isoforms of several sizes, based on proteolytic cleavage of the cytoplasmic segment (28) .
Direct comparative analysis indicated that while two mAb against f14 (3E1 and 439-9B) and two mAbs against ~6 (GoH3 and JiB5) immunoprecipitated the 170-, 150-, 135-, and 118-kD proteins, only L280 immunoprecipitated an additional gp98 subunit (Fig. 4 A) . Although 31 integrin is expressed on Colo-205 cells, anti-ill mAb did not coimmunoprecipitare f14, c~6, or gp98 subunits (not shown). Since a proteolytic fragment of f14 has been observed to migrate at 85 kD (26) , further studies were undertaken to provide evidence that gp98 is a distinct polypeptide. As shown in Fig. 5 , removal of N-linked oligosaccharides with endo-F reduced the mobility of the f14 and c~6 subunits by 5-10 kD consistent with prior studies (25); however, gp98 was diminished to 55 kD. This high degree of N-linked glycosylation dearly distinguishes gp98 from f14 and or6. Peptide mapping experiments further indicated that gp98 is distinct from the f14 glycoprotein (not shown). Treatment with neuraminidase to remove sialic acid and O-glycanase to remove O-linked oligosaccharides resulted in only minor changes in mobility of the/34, or6, or gp98 subunits (not shown).
That f14 and or6 are components of the antigen immunoprecipitated by L280 mAb was demonstrated by the ability to affinity-purify the antigen using L280 mAb-Sepharose, elute the proteins and then reimmunoprecipitate the eluted proteins with anti-fl4, anti-or6 and L280 mAbs (Fig. 6 A) . Note that while L280 mAb reimmunoprecipitated all of the original components of the complex, anti-fl4 and anti-or6 only immunoprecipitated the higher tool wt structures and not gp98. This suggests that anti-fl4 and anti-c~6 are unable to react with gp98. L280 mAb directly binds to the o~6,fl4 integrin, in the absence of the gp98 glycoprotein, based on the ability of L280 mAb to reimmunoprecipitate fl4,ot6 integrin affinitypurified from Colo-205 using anti-fl4 Sepharose (Fig. 6 B) . However, L280 mAb fails to react with •4,ot6 integrin expressed on HT-29, another colon carcinoma cell line that expresses the B4,a6 integrin (Fig. 7) .
Sequential immunoprecipitation was undertaken to further explore the relationship between reactivity of L280 and the /J4,o~6 integrin (Fig. 8) . 12si lysates from Colo-205 were immunoprecipitated with L280 mAb, anti-fl4 mAb, or anti-a6 mAb to remove all reactive structures with the individual antibodies. Depletion with anti-fl4 removed all ol6 antigen. L280 mAb immunoprecipitated gp98 (and also small amounts of several higher tool wt proteins) from this 84 depleted lysate. After depletion of o~6, residual f14 was immunoprecipitated with anti-~4, and f14 and gp98 were detected with L280 mAb. Similarly, after depletion of antigen with L280, detectable amounts of~4 and o~6 remained. These results indicate that a subset of the B4,ot6 integrin molecules are reactive with L280 mAb, and that anti-fl4 and anti-oe6 mAb are unreactive with gp98. Moreover, these preclearing experiments demonstrate that/34,o~6 integrin is a major component of the 125I-labeled membrane glycoproteins reactive with L280 mAb.
Collectively, these results suggest that L280 mAb recognizes an epitope that is expressed both on the/J4,oL6 integrin and the gp98 glycoprotein on the surface of Colo-205. However, since L280 mAb failed to react with fl4,cz6 integrin on the HT-29 cell line, the most plausible interpretation is that L280 mAb reacts with a carbohydrate antigen shared between B4,oe6 and gp98. Preliminary attempts to deglycosylate B4,ot6 and gp98 before binding with L280 mAb provided inconclusive results. However, a common feature of carbohydrate antigens is their resistance to denaturation by boiling, whereas polypeptide antigens are often destroyed by this treatment. As shown in Fig. 9 , the antigenic determinants recognized by L280 mAb in fact were resistant to boiling. By contrast, reactivity of [34,~6 with anti-[34 and anti-or6 mAbs was labile to this treatment. However, it should be appreciated that if the antigen recognized by L280 is actually carbohydrate, this structure apparently is restricted in expression to secretory epithelial tissues.
Effect of mAb against [34 and cx6 on Natural Killer (NK) Cellmediated Cytotoxicity.
MAb against c~6 or [34 failed to affect the cytotoxicity mediated by NK clones (Fig. 10) or polyclonal IL-2-activated NK cell cultures from several donors (not shown), demonstrating the specificity of the inhibition observed with the L279, L280, and L281 mAb. The mechanism whereby L280 mAb inhibits NK ceU-mediated cytotoxicity has not as yet been determined. Preliminary studies to examine the ability of L280 mAb to affect NK cell conjugate formation with Colo-205 target cells have proven inconclusive. L280 mAb does not modulate expression of the antigen from the surface of Colo-205 even after overnight culture in saturating concentrations of mAb (not shown).
As yet, ligands for the [34,cx6 integrin have not yet been identified, although it has been suggested that laminin may bind to B4,oL6 on certain cell lines (29) . Laminin fails to affect mAb, GRGDSP peptide, GRGESP control peptide, human laminin, and mAb against ~1 (AIIB2), B4 (3E1), o~6 (GoH3) E/T ratio was 3:1. For inhibition assays, human laminin, GRGDSP, and GR.GESP were used at 100/~g/ml and mAb were used at 10/zg/ml or at saturating concentrations of hybridoma supernatant and were added to the targets 30 min before effector cells. cates that the L280 antigen must interact with a receptor or cellular ligand present on the surface of NK cells. The "target-specific" receptors on NK cells are unknown; therefore, it is impossible to distinguish between the possibilities that the L280 antigen on Colo-205 serves as a "target-antigen" for NK cells or serves a more general role as an accessory cell molecule. Since the TcR is well characterized, we under-took experiments to determine whether L280 mAb affects specific immune interactions between T lymphocytes and Colo-205 cells. CTL were generated against Colo-205 cells in a mixed lymphocyte/tumor cell culture. CTL lines were established that demonstrated cytotoxicity against Colo-205 (Fig. 11) . Cytotoxicity mediated by these CTL cell lines was inhibited by anti-CD3 and anti-HLA-mAbs, demonstrating that the effector cells were CD3 + CTL and likely recognized allogeneic HLA on the Colo-205 targets. L280 mAb efficiently blocked CTL-mediated cytotoxicity against Colo-205 targets. CD8 + CTL clones established from these polyclonal cell lines also lysed Colo-205 cells and were blocked by anti-CD3, anti-HLA, anti-CD8 and L280 mAbs (not shown). These results dearly demonstrated that the antigen identified by L280 mAb participates in immune interactions between CTL and Colo-205. Since antigen-specific recognition is undoubtedly mediated by the TCR, these findings suggest that the L280 antigen serves an accessory role and that the receptor for L280 antigen is present on T lymphocytes in addition to NK cells.
While experiments using CTL generated against Colo-205 demonstrate that the L280 antigen can function in T cell interactions, it is possible that this is a rare event and that T cells capable of using this accessory molecule were selected in vitro during the MLR. Therefore, to obtain an unbiased assessment, CTL clones generated against B lymphoblastoid cell lines were tested for inhibition with L280 mAb (Fig. 11) . Colo-205 expresses HLA-A2, therefore several weU-characterized HLA-A2 alloantigen specific CTL clones were available for analysis. CTL clones JS86 (15) and ES204 (16) are HLA-A2 specific, and express otl3-TCR and 3~-TCR, respectively. These effectors killed Colo-205, as well as JY, an HLA-A2 bearing B lymphoblastoid cell line. Cytotoxicity against Colo-205, but not JY, was essentially completely inhibited by L280 mAb. Since these alloantigen-specific CTL lines were selected and re-stimulated using B lymphoblastoid cells, there was no preselection for use of the L280 accessory cell molecule. Therefore, we conclude that the receptor for L280 antigen is expressed on CTL without deliberate induction or selection.
Since the physiological role of alloantigen recognition is unclear, further studies were undertaken to determine whether the L280 antigen is also involved in HLA-restricted, peptidespecific T cell recognition. CTL Q66.40 is a CD8 + , c~-TCR + T cell clone that specifically recognizes influenza virus matrix peptide 59-68 in conjunction with HLA-A2 (S. Verma, H. Spits, and R. de Waal Malefyt, manuscript in preparation). As shown in Fig. 12 , CTL Q66.40 did not kill JY or Colo-205. However, strong cytolytic activity was observed against these targets after pre-incubated with specific influenza peptide. L280 mAb efficiently blocked HLA-A2 restricted, peptide-specific lysis of Colo-205, but not JY targets.
In summary, we have identified a novel accessory cell molecule that is involved in both NK and T cell-mediated cytotoxicity. Given the distribution of staining with L280 mAb, this molecule may participate in the interaction between lymphocytes and epithelial cells in numerous tissues and may be of relevance in CTL or NK cell-mediated immunity against virus-infected epithelial cells. Biochemical analysis suggests that the epitope recognized by L280 mAb is possibly carbohydrate in nature and is expressed on both the ~4,ct6 integrin, as well as another previously unidentified glycoprotein, designated gp98. The L280 antigen may interact with an as yet unknown counter-receptor (or ligand) on the membrane of NK and ot~-TCR + and ),/~-TCR + T cells. If the L280 antigen is a carbohydrate, its receptor on lymphocytes could conceivably possess lectin-binding domains, similar to the recently described lectin cell adhesion molecule family of cell adhesion molecules (31, 32) . Alternatively, it is possible that while L280 mAb reacts with a carbohydrate epitope, the protein attached to this oligosaccharide may in fact be responsible for the interaction. Therefore, further studies are necessary to explore the role of~4, ct6 integrin in possible epithelial ceil/lymphocyte interactions, as well as to elucidate the structure and function of the gp98 glycoprotein.
